Small Talk: The engineers who are building human tissue

The possible discovery of flowing water on Mars is yet another example of how science fiction is becoming science fact. And it's not just in outer space.

Back on earth, just look at the area of regenerative medicine, which uses donor tissue from either humans or animals (most commonly, pigs) to patch up patients suffering everything from heart disease to diabetes.

Tissue Regenix, which launched on the Alternative Investment Market (AIM) last summer, hopes to be a key player in this nascent industry. Using tissue-engineering research pioneered by Professor Eileen Ingham and Professor John Fisher at the University of Leeds, the company has patented an innovative way of stripping the cells away from the donor structure – a heart valve, for example – leaving only the generic collagen structure to be implanted. The patient's own body then overlays the "biological scaffolding" with its own tissues.

The potential market is massive, given the perpetual shortages of human donors. The use of immuno-suppressant drugs to counteract the rejection of foreign tissues is a far-from-ideal long-term solution.

Tissue Regenix has a range of different applications for its technology, but the most eye-catching in the current corporate climate is its woundcare product. The stripped-down skin patch for use treating diabetic ulcers is currently being trialled by the NHS.

Meanwhile, there are growing signs that the much-predicted consolidation is ramping up in the woundcare sector.

Last month, Apax spent $6.3bn (£3.8bn) buying New York-listed KCI, a medical technology group whose fastest-growing segment is its woundcare business. And in May, pharma giant Shire snapped up Advanced BioHealing, a direct competitor to Tissue Regenix in the regeneration space.

Last week, Tissue Regenix received its first overview by City analysts. Peel Hunt, which took over as house broker in November, describes the company as "one of the most exciting medical device opportunities". It is one to watch.

Breathing easy with Vectura

Respiratory specialist Vectura last week announced two licensing deals for the development of its VR315 treatment for asthma and COPD, a smoking-induced breathing problem.

Catchily-named VR315 is a generic version of a branded therapy which commands a whopping $8bn market worldwide. Vectura's copy is already licensed in Europe, to Swiss drugs giant Novartis, and expected to go on the market within the coming year or so.

As of Wednesday, it is also licensed for the US market – with a company which remains anonymous for commercial reasons. And on Friday Vectura announced an agreement for the rest of the world, in a second deal with the Novartis generics division, Sandoz.

"This is a real step change for Vectura," Chris Blackwell, the chief executive, said. "It puts us in a really strong position."

VR315 is not the only major development the company is working on. Two more major products – which also treat COPD – will come to fruition in the next one to two years, and are expected to give a major boost to revenues.

The company is garnering considerable support amongst City analysts. Peel Hunt's Stefan Hamill described the latest VR315 licensing deals as "a signal of confidence" that "puts to rest any lingering doubts over Vectura's technology. "In a week where growth and sovereign concerns have come further to the fore, Vectura offers a structural play on austerity," he says.

Investors seem to agree. The company's stock rose by 2 per cent on Friday – taking it up by more than 100 per cent over the last 12 months – despite the turmoil in the world's equity markets.

A new way to tempt investors

With credit still tight and few interesting initial public offerings to tempt investors, Patrick Gruhn, the founder of Elevator investment magazine, has turned his sights to the private equity market.

FirstPEX – billed by Mr Gruhn as Europe's first secondary market for private equity investments – was soft launched in Switzerland last month and is set to go live in the UK by the end of this year.

Small British companies and entrepreneurs will be able to list on the site, offering holdings to registered investors, who will also be able to trade their stakes online. The technology allows buyers and sellers to trade, via a traditional auction process, with no intermediaries and with complete transparency as to bid-offer prices.

"The idea is simple: provide a solution for investors and business owners to trade non-liquid assets in a swift and cost-efficient manner," Mr Gruhn explains.

LPO Ventures – the company set up by Mr Gruhn to create FirstPEX – expects trading to hit more than €1bn (£871m) over the next 12 to 18 months, and to €10bn by 2015.

At the moment, British companies can list on the site, but the only registered buyers are Swiss (of which there are around 80, so far). But by the end of the year the market will be opened up to investors from the UK as well.

Start your day with The Independent, sign up for daily news emails
ebooks
ebooksAn introduction to the ground rules of British democracy
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Recruitment Genius: Sales Assistant / Buyer

£15000 - £17000 per annum: Recruitment Genius: This company offers a range of ...

Recruitment Genius: Customer Service Advisor

£15000 - £16000 per annum: Recruitment Genius: Customer Service Advisors are r...

SThree: Trainee Recruitment Consultant

£20000 - £25000 per annum + OTE £45K: SThree: SThree were established in 1986....

Recruitment Genius: Compliance Manager

£40000 - £60000 per annum: Recruitment Genius: A Compliance Manager is require...

Day In a Page

John Palmer: 'Goldfinger' of British crime was murdered, say police

Murder of the Brink’s-MAT mastermind

'Goldfinger' of British crime's life ended in a blaze of bullets, say police
Forget little green men - aliens will look like humans, says Cambridge University evolution expert

Forget little green men

Leading evolutionary biologist says aliens will look like humans
The Real Stories of Migrant Britain: An Algerian scientist adjusts to life working in a kebab shop

The Real Stories of Migrant Britain

An Algerian scientist struggles to adjust to her new life working in a Scottish kebab shop
Bodyworlds museum: Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy

Dying dream of Doctor Death

Dr Gunther von Hagens has battled legal threats, Parkinson's disease, and the threat of bankruptcy
UK heatwave: Temperature reaches 39.8 degrees on Central Line - the sweatiest place in London

39.8 degrees recorded on Tube

There's hot (London) and too damn hot (the Underground). Simon Usborne braved the Central line to discover what its passengers suffer
Kitchens go hi-tech: From robot chefs to recipe-shopping apps, computerised cooking is coming

Computerised cooking is coming

From apps that automatically make shopping lists from your recipe books to smart ovens and robot chefs, Kevin Maney rounds up innovations to make your mouth water
Jessie Cave interview: The Harry Potter star has published a feminist collection of cartoons

Jessie Cave's feminist cartoons

The Harry Potter star tells Alice Jones how a one-night stand changed her life
Football Beyond Borders: Even the most distruptive pupils score at homework club

Education: Football Beyond Borders

Add football to an after-school homework club, and even the naughtiest boys can score
10 best barbecue books

Fire up the barbie: 10 best barbecue books

We've got Bibles to get you grilling and smoking like a true south American pro
Wimbledon 2015: Nick Bollettieri - Junk balls and chop and slice are only way 5ft 1in Kurumi Nara can live with Petra Kvitova’s power

Nick Bollettieri's Wimbledon Files

Junk balls and chop and slice are only way 5ft 1in Kurumi Nara can live with Petra Kvitova’s power
Ron Dennis exclusive: ‘This is one of the best McLaren teams ever – we are going to do it’

‘This is one of the best McLaren teams ever – we are going to do it’

Ron Dennis shrugs off a poor start to the season in an exclusive interview, and says the glory days will come back
Seifeddine Rezgui: What motivated a shy student to kill 38 holidaymakers in Tunisia?

Making of a killer

What motivated a shy student to kill 38 holidaymakers in Tunisia?
UK Heatwave: Temperatures on the tube are going to exceed the legal limit for transporting cattle

Just when you thought your commute couldn't get any worse...

Heatwave will see temperatures on the Tube exceed legal limit for transporting cattle
Exclusive - The Real Stories of Migrant Britain: Swapping Bucharest for London

The Real Stories of Migrant Britain

Meet the man who swapped Romania for the UK in a bid to provide for his family, only to discover that the home he left behind wasn't quite what it seemed
Cheaper energy on the way, but it's not all sunshine and rainbows

Cheaper energy on the way, but it's not all sunshine and rainbows

Solar power will help bring down electricity prices over the next five years, according to a new report. But it’s cheap imports of ‘dirty power’ that will lower them the most